Reporter brief
Exercise during cancer treatment may affect fitness and immune markers in breast cancer patients.
What happened
PhActHealth is a multicenter RCT enrolling women with newly diagnosed luminal B or triple-negative breast cancer. Participants were randomly assigned to lifestyle counseling alone (control) or counseling plus a personalized aerobic and resistance exercise program during neoadjuvant treatment. The study measured exercise capacity as the primary outcome, with secondary outcomes including immune response, autonomic nervous system regulation, cardiovascular health, and tumor aggressiveness markers.
Why it matters
Assessment pending; this report does not establish a change in evidence.
What it does NOT prove
- Limitations have not been recorded; consult the primary source.
Study design and sample
Rct; Human.
Women with newly diagnosed luminal B or triple-negative breast cancer who are candidates for neoadjuvant therapy.
- Design
- Rct
- Sample
- —
- Journal
- University of Milan
- Published
- Aug 20, 2026
Effect size
Not recorded.
Caveats
- Assessment: Superseded.
- Only the source material recorded on this evidence page was assessed.
Conflicts and funding
Not recorded.
Previous evidence
See the Exercise timeline and recorded assessment for prior evidence.
Primary source
Cancel Death charts and briefs may be reproduced editorially with attribution to CancelDeath.com. This brief is generated from the primary recorded source facts and assessment. Its review status is shown below; verify quotations against the paper before publication.